| Members |
targetComponentId |
| Transorbital |
Transorbital approach |
| Transplant of lymphatic structure (procedure) |
Transplantation of lymphatic structure |
| Transrectal biopsy of prostate |
Transrectal needle biopsy of prostate (procedure) |
| Transsexualism (disorder) |
Transsexual (finding) |
| Transsexualism NOS |
Transsexual (finding) |
| Transsexualism, previously asexual |
Previously asexual transsexual (finding) |
| Transsexualism, previously heterosexual |
Previously heterosexual transsexual (finding) |
| Transsexualism, previously homosexual |
Previously homosexual transsexual (finding) |
| Transsexuality with asexual history |
Previously asexual transsexual (finding) |
| Transsexuality with heterosexual history (disorder) |
Previously heterosexual transsexual (finding) |
| Transsexuality with homosexual history |
Previously homosexual transsexual (finding) |
| Transsexuality with unspecified sexual history |
Transsexual (finding) |
| Transthoracic echocardiography |
Transthoracic echocardiography (procedure) |
| Transverse presentation (disorder) |
Transverse lie |
| Transvestism |
Cross-dressing |
| Trastuzumab |
Trastuzumab (substance) |
| Traumatic perforation |
Perforating wound |
| Traumatic skin changes |
Injury to skin caused by trauma |
| Travel vaccination given |
Travel vaccination given |
| Treatment of glaucoma (product) |
anti glaucoma preparation |
| Treponema pallidium (organism) |
Treponema pallidum |
| Tretinoin 0.05% liquid (product) |
Tretinoin 500 microgram/mL cutaneous solution |
| Trial of micturition without catheter |
Trial without catheter (regime/therapy) |
| Triamcinolone acetonide 100mcg/spray (product) |
Product containing only triamcinolone (medicinal product) |
| Triamcinolone acetonide 3mg injection suspension ampule 1mL (product) |
Triamcinolone acetonide 3 mg/mL suspension for injection |
| Triamcinolone acetonide 40mg injection suspension ampule (product) |
Triamcinolone only product in parenteral dose form |
| Triamcinolone acetonide 40mg/mL suspension (product) |
Product containing only triamcinolone (medicinal product) |
| Triamcinolone diacetate 25mg/mL injection suspension ampule (product) |
Triamcinolone diacetate 25 mg/mL suspension for injection |
| Triamcinolone diacetate 40mg/mL injection suspension ampule (product) |
Product containing precisely triamcinolone diacetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
| Triazole derivative (substance) |
Substance with triazole structure (substance) |
| Tribavirin 6g inhalation (pdr for recon) (product) |
Product containing precisely ribavirin 20 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
| Trichoglossus haematodos forsteni |
Trichoglossus forsteni (organism) |
| Trichomoniasis of other sites (disorder) |
Infection caused by Trichomonas (disorder) |
| Trichosporon capitatum (organism) |
Saprochaete capitata |
| Triclofos sodium allergy |
Allergy to triclofos |
| Triclosan 2% bath additive |
Triclosan 20 mg/mL cutaneous solution |
| Triethanolamine polypeptide oleate condensate 10% solution (product) |
Product containing only triethanolamine in otic dose form (medicinal product form) |
| Trifluoperazine hydrochlorid 1mg tablet (product) |
Product containing precisely trifluoperazine (as trifluoperazine hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) |
| Trifluoperazine hydrochlorid 5mg tablet (product) |
Product containing precisely trifluoperazine (as trifluoperazine hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug) |
| Trifluoperazine hydrochloride 10mg/mL solution (product) |
Trifluoperazine 10 mg/mL oral solution |
| Trigemino-sympathetic syndrome (disorder) |
Paratrigeminal syndrome |
| Trihexyphenidyl hydrochloride 5mg m/r capsule (product) |
Product containing only trihexyphenidyl in oral dose form (medicinal product form) |
| Trihexyphenidyl hydrochloride 5mg prolonged-release oral capsule |
Product containing only trihexyphenidyl in oral dose form (medicinal product form) |
| Trimellitic anhydride specific extract (product) |
Trimellitic acid |
| Trimesters |
Maternal antenatal period |
| Trimethobenzamide 100mg/mL (product) |
Trimethobenzamide hydrochloride 100 mg/mL solution for injection |
| Trimethobenzamide hydrochlor 100mg/mL solution (product) |
Trimethobenzamide hydrochloride 100 mg/mL solution for injection |
| Trimethobenzamide hydrochloride 100 mg/mL intramuscular solution (product) |
Trimethobenzamide hydrochloride 100 mg/mL solution for injection |
| Trimethobenzamide hydrochloride 100mg suppositories (product) |
Product containing precisely trimethobenzamide (as trimethobenzamide hydrochloride) 100 milligram/1 each conventional release rectal suppository (clinical drug) |
| Trimethobenzamide hydrochloride 100mg/mL bar (product) |
Product containing precisely trimethobenzamide (as trimethobenzamide hydrochloride) 100 milligram/1 each conventional release rectal suppository (clinical drug) |
| Trimethobenzamide hydrochloride 100mg/mL injection solution ampule |
Trimethobenzamide hydrochloride 100 mg/mL solution for injection |
| Trimethobenzamide hydrochloride 200mg suppository (product) |
Product containing precisely trimethobenzamide (as trimethobenzamide hydrochloride) 200 milligram/1 each conventional release rectal suppository (clinical drug) |
| Trinitrotoluene |
Trinitrotoluene (substance) |
| Triphalangeal thumbs with onychodystrophy |
Deafness, onychodystrophy, osteodystrophy, intellectual disability syndrome (disorder) |
| Triphosphoric monoester hydrolase |
Triphosphoric monoester hydrolase |
| Triptorelin pamoate 11.25mg/vial lyophilized powder for conventional release suspension for injection (product) |
Triptorelin only product in parenteral dose form |
| Triptorelin pamoate 11.25mg/vial powder (product) |
Triptorelin only product in parenteral dose form |
| Triptorelin pamoate 3.75mg/vial lyophilized powder for conventional release suspension for injection (product) |
Triptorelin only product in parenteral dose form |
| Triptorelin pamoate 3.75mg/vial powder (product) |
Triptorelin only product in parenteral dose form |
| Trisodium edetate allergy |
Allergy to edetate (finding) |
| Tritiarchium (organism) |
Tritirachium |
| Tritiarchium oryzae (organism) |
Tritirachium oryzae |
| Trophic ulcer (disorder) |
Neurogenic ulcer |
| Tropicamide 0.5% conventional release eye drops |
Product containing precisely tropicamide 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
| Tropicamide 0.5% single-use eye drops (product) |
Product containing precisely tropicamide 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
| Tropicamide 1% conventional release eye drops (product) |
Product containing precisely tropicamide 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
| Tropicamide 1% single-use eye drops (product) |
Product containing precisely tropicamide 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
| Trout - dietary |
Trout (substance) |
| True bug (organism) |
Order Hemiptera (organism) |
| True histiocytic lymphoma (morphologic abnormality) |
Histiocytic sarcoma |
| Trunk flap |
Flap (substance) |
| Trypan blue 0.06% ophthalmic solution (product) |
Trypan blue stain only product |
| Trypan blue 1.5mg/mL ophthalmic solution |
Trypan blue stain only product |
| Tryptase |
Tryptase |
| Tsukamurella wratislaviensis |
Rhodococcus wratislaviensis |
| Tubal abortion |
Miscarriage of tubal ectopic pregnancy |
| Tubal-cornual placenta |
Cornual placenta accreta |
| Tuberculin PPD 100,000units/mL injection solution 1mL ampule (product) |
Product containing precisely tuberculin purified protein derivative 100000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Tuberculin PPD 1:10,000(10units/mL) injection solution 1mL ampule (product) |
Product containing precisely tuberculin purified protein derivative 10 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Tuberculin PPD 1:100(1000units/mL) injection solution 1mL ampule (product) |
Tuberculin purified protein derivative 1000 unit/mL solution for injection |
| Tuberculin PPD 1:1000(100units/mL) injection solution 1mL ampule (product) |
Product containing precisely tuberculin purified protein derivative 100 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Tuberculin, purified protein 1u/mL injection solution vial (product) |
Tuberculin purified protein derivative 50 unit/mL solution for injection |
| Tuberculosis of cervical lymph nodes |
lymphadénite cervicale tuberculeuse |
| Tuberculosis of other female genital organs (disorder) |
Tuberculosis of female genital organs |
| Tuberculosis of other specified bone (disorder) |
tuberculose osseuse |
| Other primary progressive tuberculosis |
Primary progressive tuberculosis |
| Tuberculosis of other urinary organs |
Tuberculosis of urinary organs |
| Tuberculosis of peritoneum (disorder) |
péritonite tuberculeuse |
| Tuberculous |
Tuberculous (qualifier value) |
| Tuberculous spondylitis (disorder) |
tuberculose de la colonne vertébrale |
| Tubular adenoma - category (morphologic abnormality) |
Benign tubular adenoma (morphologic abnormality) |
| Tubular adenoma, no ICD-O subtype |
Benign tubular adenoma (morphologic abnormality) |
| Tumor stage T1a (finding) |
cT1a |
| Tumor stage T1a1 (finding) |
American Joint Committee on Cancer cT1a1 (qualifier value) |
| Tumor stage T1a2 (finding) |
American Joint Committee on Cancer cT1a2 (qualifier value) |
| Tumor stage T1b (finding) |
cT1b |
| Tumor stage T1b1 (finding) |
American Joint Committee on Cancer cT1b1 (qualifier value) |
| Tumor stage T1b2 (finding) |
American Joint Committee on Cancer cT1b2 (qualifier value) |
| Tumor stage T1c (finding) |
American Joint Committee on Cancer cT1c (qualifier value) |
| Tumor stage T1mic (finding) |
cT1mi |
| Tumor stage T2a (finding) |
cT2a |
FHIR